Skeletal Lipocalin-2 Is Associated with Iron-Related Oxidative Stress in ob/ob Mice with Sarcopeniaopen access
- Authors
- Choi, Eun Bee; Jeong, Jae Hun; Jang, Hye Min; Ahn, Yu Jeong; Kim, Kyu Hyeon; An, Hyeong Seok; Lee, Jong Youl; Jeong, Eun Ae; Lee, Jaewoong; Shin, Hyun Joo; Kim, Kyung Eun; Roh, Gu Seob
- Issue Date
- May-2021
- Publisher
- MDPI
- Keywords
- lipocalin-2; iron; inflammation; oxidative stress; sarcopenia; ob; ob mouse
- Citation
- ANTIOXIDANTS, v.10, no.5
- Indexed
- SCIE
SCOPUS
- Journal Title
- ANTIOXIDANTS
- Volume
- 10
- Number
- 5
- URI
- https://scholarworks.bwise.kr/gnu/handle/sw.gnu/3784
- DOI
- 10.3390/antiox10050758
- ISSN
- 2076-3921
- Abstract
- Obesity and insulin resistance accelerate aging-related sarcopenia, which is associated with iron load and oxidative stress. Lipocalin-2 (LCN2) is an iron-binding protein that has been associated with skeletal muscle regeneration, but details regarding its role in obese sarcopenia remain unclear. Here, we report that elevated LCN2 levels in skeletal muscle are linked to muscle atrophy-related inflammation and oxidative stress in leptin-deficient ob/ob mice. RNA sequencing analyses indicated the LCN2 gene expression is enhanced in skeletal muscle of ob/ob mice with sarcopenia. In addition to muscular iron accumulation in ob/ob mice, expressions of iron homeostasis-related divalent metal transporter 1, ferritin, and hepcidin proteins were increased in ob/ob mice compared to lean littermates, whereas expressions of transferrin receptor and ferroportin were reduced. Collectively, these findings demonstrate that LCN2 functions as a potent proinflammatory factor in skeletal muscle in response to obesity-related sarcopenia and is thus a therapeutic candidate target for sarcopenia treatment.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medicine > Journal Articles

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.